Dermata Therapeutics, Inc. — Form 8-K
Filed October 29, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 5/100
What the filing says
Dermata Therapeutics, Inc. (market cap ~$3.1M) filed a Form 8-K on 2026-10-29 reporting Item 8.01 (Other Events). The actual text of the event disclosure is not provided in this filing summary — only the structural metadata (filing date, accession number, document format) is visible. No dollar amounts, counterparties, share counts, dates of transactions, or material business changes are disclosed in the available text.
Why this rating
Filing is structural/administrative; substantive event details absent or immaterial from visible text excerpt.
Extracted items
See more from October 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.